COVID-19 vaccine benefits outweigh risk of Bell’s palsy, say researchers
The benefits and efficacy of COVID-19 vaccines far outweigh the minimal risk of developing Bell’s palsy, researchers have said.
Following the first large-scale population-based study...
Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk
Researchers have made a significant breakthrough in the development of an intranasal COVID-19 vaccine.
Scientists from Lancaster University have carried out pre-clinical trials of a...
Greater effort needed to reduce antimicrobial resistance, researchers say
Current measures to reduce antibiotic prescribing in primary care are not enough to prevent the rise of drug-resistant infection in England, a new report...
The pharmaceutical industry’s response to COVID-19
Nathalie Moll, Director General of the EFPIA, discusses the changes the pharmaceutical industry has implemented to support the healthcare sector through COVID-19.
The European Federation...
New drug offers hope for MS sufferers on World Brain Day
As medical experts urgently call for action to tackle MS, one company has developed a drug it believes can treat the condition by repairing...
Longer interval between Pfizer vaccine doses boosts antibody protection
A longer dosing schedule for the Pfizer COVID-19 vaccine triggered the most effective immune response, new research has found.
A new and extensive pre-print study...
Antipsychotic drug could reduce dementia-related psychosis symptoms
The benefits of an antipsychotic treatment for people with dementia-related psychosis have been demonstrated in a new study.
A clinical trial has tested the efficacy...
Modifying the immune system could enhance vaccine efficacy
Vaccine efficacy could be enhanced using new insights about the immune system, researchers say.
Immunologists at St. Jude Children's Research Hospital have discovered a biological...
Sleep apnoea severity can be reduced by repurposed drugs
Existing medications could be repurposed to successfully reduce the severity of sleep apnoea by at least 30%, new research has revealed.
Professor Danny Eckert, Principal...
AI technology identifies 160 possible new drug treatments for COVID-19
Scientists have discovered a total of 200 approved drugs that could treat COVID-19, but only 40 are currently being tested in clinical trials.
Researchers from...
CoronaVac COVID-19 vaccine safe for children as young as three
A clinical trial has proven that the CoronaVac COVID-19 vaccine is safe for children and adolescents aged between three to 17.
The CoronaVac vaccine, which...
Promising bladder cancer treatment developed using alternative approach
Using a new approach to molecular drug design, scientists have created a highly promising bladder cancer treatment.
The new drug to treat bladder cancer was...
Antacids may improve blood sugar control in people with diabetes
Antacids can improve blood sugar control in people with diabetes, new research has demonstrated.
In a recent meta-analysis, researchers found that the use of antacids...
Understanding COVID-19 and the vaccine cold chain
B Medical Systems discusses the importance of reliable, high quality bio-medical storage and the crucial impact of the vaccine cold chain.
Optimal cold chain infrastructures...
App aids safe prescribing of COVID-19 treatment drugs
A new mobile app has been launched to advise on the safe prescribing of experimental drugs for the treatment of COVID-19.
The University of Liverpool...
Statin use reduced risk of cancer in heart failure patients
Statin use can lessen the risk of cancer and mortality in heart failure patients, new research has found.
Academics at the University of Hong Kong...
Fertility treatment drugs do not increase breast cancer risk
Common fertility treatment drugs used to release eggs do not increase the risk of developing breast cancer, new research has shown.
An analysis was carried...
Intellectual property and vaccine equality in a pandemic
Akshaya Kumar, Director of Crisis Advocacy at Human Rights Watch, speaks to us about intellectual property and vaccine inequity.
In October 2020, representatives of India...
AstraZeneca treatment unsuccessful at preventing symptomatic COVID-19
AstraZeneca’s antibody treatment – AZD7442 – has been unsuccessful in preventing symptomatic COVID-19 in patients recently exposed to the SARS-CoV-2 virus.
The results of AstraZeneca’s...
Rise in cost and usage of antidepressants sparks concern
An alarming surge in the usage and cost of antidepressants in 2020 has been recorded by researchers from the University of Huddersfield.
Researchers conducted a...
